GO:0006576 |
Cellular biogenic amine metabolic process
|
1.33 |
2.63E − 02 |
GO:0044106 |
Cellular amine metabolic process
|
1.33 |
2.63E − 02 |
GO:0046885 |
Regulation of hormone biosynthetic process
|
−1.40 |
3.17E − 02 |
GO:0051004 |
Regulation of lipoprotein lipase activity
|
−1.32 |
3.28E − 02 |
GO:0070874 |
Negative regulation of glycogen metabolic process
|
−1.44 |
3.39E − 02 |
GO:0032106 |
Positive regulation of response to extracellular stimulus
|
−1.48 |
3.45E − 02 |
GO:0032109 |
Positive regulation of response to nutrient levels
|
−1.48 |
3.45E − 02 |
GO:0031442 |
Positive regulation of mRNA 3′-end processing
|
−1.24 |
3.57E − 02 |
GO:0043001 |
Golgi to plasma membrane protein transport
|
−1.41 |
3.64E − 02 |
GO:2000973 |
Regulation of pro-B cell differentiation
|
−1.69 |
3.77E − 02 |
GO:0032494 |
Response to peptidoglycan
|
1.40 |
3.85E − 02 |
GO:0006400 |
tRNA modification
|
1.50 |
3.92E − 02 |
GO:0045807 |
Positive regulation of endocytosis
|
−1.34 |
4.11E − 02 |
GO:0006970 |
Response to osmotic stress
|
−1.15 |
4.17E − 02 |
GO:0090199 |
Regulation of release of cytochrome c from mitochondria
|
1.29 |
4.35E − 02 |
GO:0042953 |
Lipoprotein transport
|
−1.18 |
4.35E − 02 |
GO:0044872 |
Lipoprotein localization
|
−1.18 |
4.35E − 02 |
GO:0061418 |
Regulation of transcription from RNA polymerase II promoter in response to hypoxia
|
−1.52 |
4.35E − 02 |
GO:0048644 |
Muscle organ morphogenesis
|
−1.70 |
4.35E − 02 |
GO:0022615 |
Protein to membrane docking
|
−1.49 |
4.41E − 02 |
GO:0035563 |
Positive regulation of chromatin binding
|
1.55 |
4.44E − 02 |
GO:0048259 |
Regulation of receptor-mediated endocytosis
|
−1.25 |
4.48E − 02 |
GO:0032922 |
Circadian regulation of gene expression
|
−1.25 |
4.55E − 02 |
GO:0006694 |
Steroid biosynthetic process
|
−1.37 |
4.55E − 02 |
GO:2001014 |
Regulation of skeletal muscle cell differentiation
|
−1.57 |
4.55E − 02 |
GO:2000641 |
Regulation of early endosome to late endosome transport
|
−1.31 |
4.62E − 02 |
GO:0043112 |
Receptor metabolic process
|
−1.25 |
4.69E − 02 |
GO:0006891 |
Intra-Golgi vesicle-mediated transport
|
−1.38 |
4.69E − 02 |
GO:0035330 |
Regulation of hippo signalling
|
−1.44 |
4.69E − 02 |
GO:0035640 |
Exploration behavior
|
−1.47 |
4.69E − 02 |
GO:0006270 |
DNA replication initiation
|
1.46 |
4.76E − 02 |
GO:0031536 |
Positive regulation of exit from mitosis
|
1.29 |
4.76E − 02 |
GO:0048020 |
CCR chemokine receptor binding
|
−1.41 |
4.76E − 02 |
GO:0017144 |
Drug metabolic process
|
−1.42 |
4.76E − 02 |
GO:2000095 |
Regulation of Wnt signalling pathway, planar cell polarity pathway
|
−1.69 |
4.76E − 02 |
GO:0042347 |
Negative regulation of NF-kappaB import into nucleus
|
−1.37 |
4.84E − 02 |
GO:0046854 |
Phosphatidylinositol phosphorylation
|
−1.38 |
4.84E − 02 |
GO:0006901 |
Vesicle coating
|
−1.42 |
4.84E − 02 |
GO:0051045 |
Negative regulation of membrane protein ectodomain proteolysis
|
1.62 |
4.88E − 02 |
GO:0006335 |
DNA replication-dependent nucleosome assembly
|
1.51 |
4.88E − 02 |
GO:0034723 |
DNA replication-dependent nucleosome organization
|
1.51 |
4.88E − 02 |
GO:2000649 |
Regulation of sodium ion transmembrane transporter activity
|
−1.33 |
4.92E − 02 |
GO:0048260 |
Positive regulation of receptor-mediated endocytosis
|
−1.35 |
4.92E − 02 |
GO:0002381 |
Immunoglobulin production involved in immunoglobulin-mediated immune response
|
−1.36 |
4.92E − 02 |
GO:0018879 |
Biphenyl metabolic process
|
−1.45 |
4.92E − 02 |